New York, New York (PRWEB) June 06, 2014
The federal litigation established in the U.S. District Court, Southern District of West Virginia, for vaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against Ethicon, Inc. continues to move forward, Bernstein Liebhard LLP reports. According to an Order dated June 5, 2014, the Court has granted leave to the Plaintiffs’ Steering Committee to file an additional reply in support of a Defense Motion Requiring Preservation of Explanted Mesh. According to court records, a hearing on the Defense Motion has been scheduled for June 13th at 10:00 a.m. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)
“Our Firm has filed numerous claims in this proceeding on behalf of women who allegedly suffered serious vaginal mesh complications due to Ethicon devices. We are pleased to see further progress on this issue,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate transvaginal mesh lawsuits on behalf of women who suffered serious complications, allegedly due to products marketed by Ethicon and other manufacturers.
Transvaginal Mesh Lawsuits
Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs Steering Committee for the federal Ethicon litigation. Court records indicate that more than 18,000 vaginal mesh lawsuits are now pending in the proceeding. All of the lawsuits accuse Ethicon of failing to provide adequate warnings regarding the risks associated with mesh products used to treat pelvic organ prolapse and stress urinary incontinence. Plaintiffs also claim that the products were defectively designed and brought to market without adequate testing.
According to court documents, Ethicon is just one of several defendants involved in pelvic mesh litigations in the Southern District of West Virginia, where more than 55,000 vaginal mesh lawsuits have been filed. Mr. Grand is also a member of the Plaintiffs’ Steering Committees in proceedings involving: American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).
Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Alleged victims of serious vaginal mesh complications may be entitled to compensation for their injury-related damages, including medical bills, lost wages, pain and suffering, and more. To learn more about the potential risks associated with transvaginal mesh, please visit Bernstein Liebhard LLP’s website, or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP